Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 70.00
+0.90 (1.30%)
May 29, 2026, 1:30 PM CST
Crystalvue Medical Market Cap
Crystalvue Medical has a market cap or net worth of 1.77 billion as of May 29, 2026. Its market cap has decreased by -12.50% in one year.
Market Cap
1.77B
Enterprise Value
1.67B
Revenue
912.86M
Ranking
n/a
PE Ratio
12.17
Stock Price
70.00
Market Cap Chart
Since April 29, 2015, Crystalvue Medical's market cap has increased from 1.04B to 1.77B, an increase of 70.93%. That is a compound annual growth rate of 4.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.77B | -8.02% |
| Dec 31, 2025 | 1.93B | -10.37% |
| Dec 30, 2024 | 2.15B | -1.77% |
| Dec 29, 2023 | 2.19B | 76.51% |
| Dec 30, 2022 | 1.24B | 8.45% |
| Dec 30, 2021 | 1.14B | -3.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciVision Biotech | 3.91B |
| Bionime | 3.84B |
| Maxigen Biotech | 3.44B |
| ICARES Medicus | 3.44B |
| Nang Kuang Pharmaceutical | 3.28B |
| Chi Sheng Pharma & Biotech | 1.79B |
| BenQ Medical Technology | 1.66B |
| Lagis Enterprise | 1.29B |